EMERADE sol inj 300 mcg/0.3 ml stylo pré 0.3 ml
7680676200039
CH-67620
C01CA24
02.05.2.
google
Details
- Product number
- 6762002
- CPT
- -
- Packaging group
- 1 x 0.3 ml
- Unit
- Injektor(en), vorgefüllt/Pen
- Composition
- adrenalinum 300 µg ut adrenalini tartras, E 223 0.15 mg, dinatrii edetas, natrii chloridum, acidum hydrochloridum dilutum, aqua ad iniectabile q.s. ad solutionem pro 0.3 ml corresp. natrium 1.05 mg.
Articles (1)
Emerade 300 ug, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
1 x 0.3 ml
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
300.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
0.15 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.05 MG | Substance | HBESI |
Authorization holder
Curatis AG
4410 Liestal
Authorization information
- Swissmedic authorization number
- 67620
- Drug name
- Emerade, Injektionslösung im Fertigpen
- Galenic form
- INLFP
- ATC Code
- C01CA24
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 23/11/2021
- Authorization expiration date
- 31/08/2025
- IT number
- 02.05.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- EMERADE sol inj 300 mcg/0.3 ml stylo pré 0.3 ml
- Description (DE)
- EMERADE Inj Lös 300 mcg/0.3 ml Fertpen 0.3 ml
- Market launch
- 23/11/2021
- Market withdrawal
- 31/08/2025
- Narcotic (BTM)
- No